Marshall Wace Asia’s Gilead Sciences GILD Stock Holding History

Marshall Wace Asia’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-65,291	Closed	-$5.04M	–	95
2018 Q3	$5.04M	Sell	65,291 -5,802	-8%	-$438K	0.17%	59
2018 Q2	$5.04M	Buy	71,093 +19,083	+37%	+$1.35M	0.17%	55
2018 Q1	$3.92M	Buy	+52,010	New	+$4.13M	0.12%	80

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Marshall Wace Asia's GILD Position: Q4 2018 in Review

Marshall Wace Asia sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 65,291 shares — an estimated $5.04M sold.

Marshall Wace Asia first reported a position in GILD in Q1 2018 and held it in 3 quarters. The position peaked at $5.04M in Q3 2018. 1,496 funds tracked by Wall St. Rank hold GILD as of Q4 2018.

Marshall Wace Asia reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
Marshall Wace Asia sold 65,291 Gilead Sciences shares in Q4 2018, an estimated $5.04M.
Marshall Wace Asia first reported a position in Gilead Sciences in Q1 2018 and held it in 3 quarters.
Marshall Wace Asia's Gilead Sciences position peaked at $5.04M in Q3 2018.
1,496 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.

Based on Marshall Wace Asia's 13F filing for Q4 2018, filed 14 Feb 2019.